AT
Averna Therapeutics Inc.
SEC filingOther Health Care · Watertown, MA
Amount raised$85Msold at filing
Total offering$85M$5 still open
Investors in the raise13count reported to the SEC
FiledMar 20, 2026first sale Apr 8, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Thomas BarnesDirector, Executive Officer
Roy AmariglioDirector
Nick OlsenDirector
Stephen SquintoDirector
Richard MorrisExecutive Officer
Michal SilverbergDirector
Raju PrasadDirector
Tal ZaksDirector, Executive Officer
Henry ChenDirector
Dylan MorrisDirector
Executive officers, directors and promoters as listed on the Form D.